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Gene	   fusions	   are	   created	  when	   two	   or	  more	   discrete	   genes	   incorrectly	   join	   together.	  
They	  are	  common	  mutations	  in	  the	  human	  genome	  and	  often	  found	  to	  cause	  cancer	  (Nambiar,	  
Kari,	   &	   Raghavan,	   2008).	   Since	   the	   advent	   of	   next	   generation	   sequencing	   (NGS)	   technology,	  
numerous	  gene	  fusions	  in	  cancer	  tissues	  have	  been	  discovered	  and	  catalogued.	  We	  utilized	  the	  
rapidly	  growing	  pool	  of	   information	  on	  gene	  fusions	   in	  human	  cancer	  to	   identify	  gene-­‐fusion-­‐
formation	   patterns.	  We	   hypothesized	   that	   understanding	   the	  mechanisms	   and	   risk	   for	   gene-­‐
fusion	   formation	   could	   facilitate	   novel	   gene	   fusion	   detection	   in	   human	   cancers	   and	   lead	   to	  
better	  targeted	  treatments.	  This	  thesis	  project	  has	  three	  related	  computational	  analyses:	  1)	  we	  
used	  a	  motif	  discovery	  tool	  to	  examine	  common	  sequence	  patterns	  at	  and	  around	  breakpoints	  
that	  form	  fusions,	  2)	  we	  calculated	  entropy	  in	  a	  sliding-­‐window	  manner	  to	  determine	  structural	  
characteristics	  at	  and	  around	  breakpoints	  that	  form	  fusions,	  and	  3)	  we	  executed	  a	  gene-­‐fusion	  
network	   analysis	   to	   visualize	   and	   compare	   cancer-­‐associated	   gene	   fusion	   metrics	   versus	  
controls.	  
1.1. Gene	  fusion	  
A	   gene	   fusion	   is	   the	   result	   of	   two	   or	   more	   discrete	   genes	   incorrectly	   joining.	   These	  
mutations	  may	   results	   in	   fused	  mRNA	   transcripts.	   In	  most	   two-­‐gene	   gene	   fusion	   events,	   the	  
promoter	   from	   the	   gene	   in	   the	   5’	   position	   controls	   transcription.	   Gene	   fusions	   result	   from	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translocations,	   inversions,	   insertions	  or	  deletions	   and	  are	   common	  mutations.	  Nambiar	   et	   al.	  
(Nambiar	   et	   al.,	   2008)	   reports	   that	   approximately	   20%	  of	   cancers	   are	  driven	  by	   gene	   fusions	  
caused	   by	   chromosomal	   locations.	   Figure	   1-­‐1	   illustrates	   a	   gene	   fusion	   event.	   Because	   of	   the	  
estimated	   large	   percentage	   of	   cancers	   caused	   by	   gene	   fusions,	   the	   research	   community	   has	  
great	   interest	   in	   gene	   fusions	   that	   facilitate	   tumorigenesis.	   Identifying	   and	   determining	  
mechanisms	   by	   which	   gene	   fusions	   act	   lead	   to	   projections	   toward	   drug	   targets	   for	   cancer	  
treatment.	  
	  
Figure	  1-­‐1:	  An	   illustration	  of	  a	  gene	  fusion	  event.	  Lines	  represent	  genomic	  DNA	  and	  boxes	  represent	  exons.	  Gene	  A	  (blue)	  
breaks	  (at	  the	  point	  designated	  by	  slanted	  line)	  and	  fuses	  with	  Gene	  B	  (red).	  Exons	  are	  numbered	  for	  clarification.	  Each	  gene	  
has	   a	   promoter	   designated	   by	   the	   colored	   arrows	   at	   the	   beginning	   of	   the	   DNA.	   Gene	   B’s	   promoter	   is	   lost	   and	   Gene	   A’s	  
promoter	  now	  controls	  transcription	  for	  the	  fusion.	  
	  
One	   of	   the	   most	   successful	   gene	   fusion	   discoveries	   involves	   BCR-­‐ABL	   in	   chronic	  
myelogenous	   leukemia	   (CML).	   As	   early	   as	   1960,	   Nowell	   and	   Hungerford	   examined	   leukemia	  
cells	  from	  chronic	  phase	  CML	  patients	  and	  found	  a	  common	  abnormality	  -­‐	  in	  each	  of	  their	  seven	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samples,	  chromosomes	  9	  and	  22	  contained	  reciprocal	  translocations	  (P.	  C.	  Nowell,	  1960).	  Their	  
finding	  ignited	  additional	  studies	  that	  began	  to	  answer	  why	  this	  abnormality,	  which	  they	  called	  
the	   Philadelphia	   Chromosome,	   is	   associated	   with	   CML.	   Two	   genes	   are	   disrupted	   in	   a	  
Philadelphia	   chromosome.	   Abelson	  murine	   leukemia	   viral	   oncogene	   (ABL),	   translocated	   from	  
chromosome	   9,	   is	   a	   proto-­‐oncogene	   that	   encodes	   a	   tyrosine	   kinase	   and	   is	   active	   during	   cell	  
differentiation,	  cell	  division,	  cell	  adhesion,	  and	  stress	  response.	  Breakpoint	  cluster	  region	  gene	  
(BCR),	   from	   chromosome	   22,	   encodes	   a	   protein	   with	   serine/threonine	   kinase	   activity	   but	   is	  
otherwise	   uncharacterized	   at	   this	   time.	   Not	   only	   does	   a	   BCR-­‐ABL	   gene	   fusion	   occur	   on	   the	  
Philadelphia	  chromosome,	  but	  a	  novel	  mRNA	  transcript	  is	  produced	  that	  contains	  components	  
from	  both	  genes	  (Ben-­‐Neriah,	  Daley,	  Mes-­‐Masson,	  Witte,	  &	  Baltimore,	  1986).	  
Once	   the	   structural	   mutation	   on	   the	   Philadelphia	   chromosome	   was	   characterized,	  
researchers	   began	   answering	   questions	   about	   the	   relationship	   between	   the	   gene	   fusion	   and	  
CML.	   The	   fusion	   protein	   BCR-­‐ABL	   behaves	   as	   an	   abnormal	   tyrosine	   kinase	   that	   over-­‐
phosphorylates	   substrates	   and	   facilitates	   tumorigenesis	   (reviewed	   in	   (Wong	  &	  Witte,	   2004)).	  
ABL	  tyrosine	  kinase	  activation	  is	  in	  part	  regulated	  by	  a	  SH3	  domain	  which	  is	  lost	  during	  the	  gene	  
fusion	  event,	   thus	   turning	  ABL	   into	  an	  oncogene	   (Barilá	  &	  Superti-­‐Furga,	  1998).	  The	   role	  BCR	  
plays	  in	  the	  gene	  fusion	  remains	  unclear.	  There	  is	  evidence	  that	  ABL	  oligomerization	  is	  sufficient	  
for	   tumorigenesis	   but	   in	   fusions	  with	  different	  BCR	  breakpoints	   or	  with	  other	   gene	  partners,	  
ABL	  tyrosine	  kinase	  activity	  levels	  change	  (reviewed	  in	  (Wong	  &	  Witte,	  2004)).	  
Research	   identifying	   the	   BCR/ABL	   gene	   fusion	   and	   understanding	   how	   it	   leads	   to	  
tumorigenesis	  culminated	  into	  developing	  imatinib,	  a	  drug	  with	  success	  treating	  patients	  with	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CML.	  Imatinib	  is	  a	  tyrosine-­‐kinase	  inhibitor	  that	  prevents	  fusion	  protein	  BCR-­‐ABL	  activity,	  thus	  
preventing	   cancer	   cell	   growth	   (reviewed	   in	   (Wong	   &	   Witte,	   2004)).	   Since	   BCR-­‐ABL	   is	  
predominantly	  expressed	  cancer	  cells,	  imatinib	  is	  classified	  as	  a	  targeted	  therapy.	  A	  randomized	  
study	  on	  1106	  CML	  patients	  ended	  with	  96.7%	  of	  imatinib-­‐treated	  patients,	  compared	  to	  91.5%	  
of	   alternatively-­‐treated	   patients,	   classified	   as	   “free	   from	   CML	   progression”	   (O’Brien	   et	   al.,	  
2003).	   The	   drug	   passed	   clinical	   trials	   and	   is	   on	   the	  market	   as	   first-­‐line	   treatment	   since	   2001	  
(http://www.accessdata.fda.gov).	  
BCR-­‐ABL	   is	   only	   one	   of	   the	   tyrosine	   kinase	   gene	   fusions	   involved	   with	   malignancies.	  
Identified	   from	   epithelial	   tumors,	   there	   are	   currently	   ten	   tyrosine	   kinase	   genes	   that	   form	  
fusions	  with	  at	  least	  one	  partner	  gene	  (reviewed	  in	  (Shaw,	  Hsu,	  Awad,	  &	  Engelman,	  2013)).	  The	  
mechanisms	  by	  which	  tyrosine	  kinase	  fusions	  lead	  to	  tumorigenesis	  are	  similar	  across	  different	  
types	  of	   cancer	  –	   they	   involve	  deregulation	  of	   tyrosine	  kinase	  activity.	   For	  example,	   receptor	  
tyrosine	   kinase	   and	   proto-­‐oncogene	   RET	   (abbreviation	   of	   “rearranged	   during	   transfection”)	  
forms	  fusions	  with	  several	  partners	  in	  papillary	  thyroid	  cancer.	  These	  gene	  fusions	  contain	  RET’s	  
intact	   tyrosine	   kinase	   domain	   fused	   to	   the	   active	   promoter	   of	   the	   partner	   gene,	   which	  
ultimately	   leads	   to	   incessant	   MAPK	   (mitogen-­‐activated	   protein	   kinase)	   signaling	   and	  
tumorigenesis	  in	  thyroid	  cells	  (reviewed	  in	  (Nikiforov	  &	  Nikiforova,	  2011)).	  
Aberrant	   tyrosine	   kinase	   activity	   is	   not	   the	   only	   mechanism	   by	   which	   gene	   fusions	  
facilitate	   tumorigenesis.	   A	   class	   of	   gene	   fusions	   common	   in	   prostate	   cancer	   consist	   of	   an	  
androgen-­‐controlled	  genomic	  regulatory	  element	  fused	  to	  an	  oncogenic	  transcription	  factor	  in	  
the	   ETS	   (E26	   transformation	   specific,	   where	   E26	   is	   leukemia	   virus)	   family	   (Kumar-­‐Sinha,	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Tomlins,	   &	   Chinnaiyan,	   2008).	   The	   five	   prime	   partners	   in	   these	   gene	   fusions	   (for	   example,	  
TMPRSS2)	  are	  prostate-­‐specific	  and	  have	  ubiquitous	  expression.	  Fusing	  their	  promoters	  onto	  an	  
ETS	   family	  member	   leads	   to	   overexpression	  of	   oncogenic	   transcription	   factors,	  which	   in	   turn	  
leads	  to	  cellular	  pathway	  alterations	  and	  loss	  of	  tumor	  suppressor	  activity	  (reviewed	  in	  (Kumar-­‐
Sinha	  et	  al.,	  2008)).	  
There	  are	   two	  main	  mechanisms	  by	  which	  gene	   fusions	   can	   facilitate	   cancer:	   a	   fusion	  
gene	   can	   yield	   a	   chimeric	   protein	   with	   aberrant	   activity	   (e.g.	   BCR-­‐ABL),	   or	   a	   promoter	   or	  
enhancer	   can	   fuse	   to	   a	   proto-­‐oncogene	   and	   lead	   to	   overexpression	   of	   an	   oncogenic	   protein	  
(e.g.	  TMPRSS2	  fusions)	  (Aman,	  1999).	  As	  stated	  previously,	  not	  all	  gene	  fusions	  are	  pathogenic.	  
Cancer	   is	   a	   genetic	   disease	   in	   which	   cells	   accrue	   many	   mutations	   –	   some	   of	   which	   actively	  
participate	   in	   disease	   progression	   (called	   drivers),	   and	   some	   of	   which	   result	   from	   disease	  
progression	   (called	   passengers).	   Identifying	   gene	   fusions	   and	   differentiating	   drivers	   from	  
passengers	  are	  both	  current	  challenges	  in	  gene	  fusion	  research.	  
NGS	   is	  a	  sequencing	  strategy	   that	  yields	  high-­‐throughput	  and	   low-­‐cost	  sequence	  data.	  
NGS	   augments	   the	   amount	   of	   available	  whole	   genome,	   exome,	   and	   transcriptome	   sequence	  
data,	   including	   data	   from	   cancer	   tissues	   with	   gene	   fusions.	   The	   number	   of	   reported	   gene	  
fusions	   from	   tumor	   tissue	   has	   grown	   exponentially	   during	   the	   last	   six	   years.	  Mitelman	   et	   al.	  
(Mitelman,	  Johansson,	  &	  Mertens,	  2004)	  estimated	  that	  the	  number	  of	  fusion	  genes	  in	  a	  cell	  is	  
a	   linear	  function	  of	  the	  number	  of	  chromosomal	  aberrations	  	  and	  Futreal	  et	  al.	  (Futreal	  et	  al.,	  
2004)	   reported	   that	   the	   most	   common	   mutations	   in	   cancer	   are	   translocations	   that	   create	  
chimeric	  genes.	  Nevertheless,	   generating	   raw	  sequence	  data	  does	  not	  guarantee	  gene	   fusion	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identification.	   Detecting	   novel	   gene	   fusions	   in	   cancer	   enhances	   the	   current	   catalog,	   and	  
detecting	   targeted	   gene	   fusions	   facilitates	   classifying	   cancer	   types	   in	   patients.	   There	   are	  
targeted	  and	  unguided	  methods	  for	  detecting	  gene	  fusions	  in	  cancer	  tissue.	  
Targeted	   gene	   fusion	   identification	   is	   a	   necessary	   tool	   for	   translating	   gene	   fusion	  
research	  to	  clinical	  treatment.	  The	  type	  of	  cancer	  dictates	  cancer	  treatment	  -­‐	  it	  is	  advantageous	  
to	   prescribe	   a	   tyrosine	   kinase	   inhibitor	   to	   a	   patient	   with	   abnormal-­‐tyrosine-­‐kinase-­‐driven	  
cancer,	  but	  that	  treatment	  will	  be	  ineffective	  if	  the	  cancer	  stems	  from	  a	  different	  cause.	  To	  help	  
determine	   treatment,	   detecting	   the	   presence	   of	   a	   gene	   fusion	   driver	   from	   tumor	   tissue	   is	  
necessary.	  Exploring	  regions	  surrounding	  breakpoints	  highlights	  targets	  for	  directed	  gene	  fusion	  
identification.	  For	  example,	  specific	  sequence	  patters	  may	  indicate	  gene	  fusion	  presence.	  This	  is	  
the	   drive	   for	   motif	   discovery	   on	   sets	   of	   gene	   fusions	   (further	   discussed	   in	   section	   1.2).	  
Chmielecki	   et	   al.	   (Chmielecki	   et	   al.,	   2010)	  discovered	   that	  GXGXXG	  motifs	   exist	   near	   tyrosine	  
kinase	  fusions,	  and	  they	  performed	  targeted	  next	  generation	  sequencing	  around	  those	  motifs	  
to	   identify	   fusions.	   Targeted	   sequencing	   could	   identify	   suspected	   gene	   fusions	   from	   patient	  
samples	   and	   obviate	   extraneous	   sequencing.	   Another	   example	   where	   targeted	   gene	   fusion	  
detection	  assists	  in	  patient	  diagnostics	  involves	  ETS	  family	  gene	  fusions.	  ETS	  family	  gene	  fusions	  
act	   as	   biomarkers	   for	   prostate	   cancer	   and	   exist	   in	   up	   to	   70%	  of	   the	   cases	   (Thieme	  &	  Groth,	  
2013).	  The	  company	  KREATECH	  (http://www.kreatech.com)	  produces	  kits	  to	  detect	  ETS	  family	  
gene	  fusions	  with	  the	  aim	  of	  diagnosing	  prostate	  cancer.	  
Novel	   gene	   fusion	   identification	   is	   a	   tough	   problem	   to	   tackle	   and	   several	   research	  
groups	  have	  published	  methods	  to	  detect	  fusions	  from	  RNA-­‐Seq	  and	  DNA-­‐Seq	  data.	  Solutions	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involve	  constructing	  an	  algorithm	  that	  can	  align	  sequences	  and	  highlight	  anomalies	  suggesting	  
gene	   fusion	   events,	   such	   as	   exons	   from	   discrete	   genes	   present	   on	   the	   same	   sequence	   read.	  
Trans-­‐splicing,	  intergenic	  splicing,	  and	  a	  plethora	  of	  genomic	  mutations	  in	  tumor	  cells	  augments	  
type	  I	  and	  type	  II	  errors	  in	  fusion-­‐event	  screening	  against	  background	  sequences.	  To	  date,	  there	  
is	   no	   robustly	   tested	   and	   error-­‐free	   algorithm	   that	   identifies	   novel	   gene	   fusions	   from	  
sequencing	  data.	  Table	  1	   lists	  five	  recent	  algorithms	  for	  gene	  fusion	  detection,	  and	  includes	  a	  
brief	  summary	  of	  their	  results.	  The	  algorithms	  have	  different	  input	  sequence	  requirements	  and	  
limitations,	  and	  have	  each	  identified	  at	  least	  one	  novel	  gene	  fusion	  when	  evaluated.	  
The	  number	  of	  reported	  gene	  fusions	  increases,	  and	  it	  befits	  researchers	  to	  have	  access	  
to	   descriptive	   information	   on	   them.	   Public	   databases	   such	   as	   Mitelman	   and	   COSMIC	   hold	  
records	   on	   gene	   fusions	   for	   research	   aid.	   Information	   on	   the	   gene	   fusions	   includes,	   at	  
minimum,	   the	   name	   and	   position	   (5’/3’)	   of	   genes	   participating	   in	   the	   fusion.	   Additional	  
information	   can	   consist	  of	   sequence	   information,	   the	   type	  of	   cancer	   in	  which	   the	   fusion	  was	  
found,	   the	   reference	   paper,	   etc.	   Table	   2	   lists	   four	   of	   the	   current	   databases	   that	   curate	  
information	  on	  gene	  fusions.	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Table	  1:	  Summary	  of	  selected	  recent	  methods	  for	  detecting	  novel	  gene	  fusions	  
Tool	   Input	   Technique/advantages	   Limitations	   Reference	  
deFuse	   RNA-­‐Seq	  
data	  
Considers	  all	  alignments	  
rather	  than	  best-­‐fit	  
alignments.	  Considers	  
all	  locations	  for	  fusion	  
boundaries	  rather	  than	  
focus	  at	  ends	  of	  known	  
exons.	  
Requires	  at	  least	  five	  
discordant	  read	  pairs	  to	  
detect	  a	  gene	  fusion,	  which	  









Detects	  genes	  at	  the	  
transition	  regions	  where	  
copy	  number	  variations	  
occur.	  Can	  detect	  non-­‐
functional,	  silenced	  and	  
novel	  fusions	  
Detects	  fusion	  genes	  from	  
only	  unbalanced	  mutation	  
events.	  
Thieme	  &	  Groth,	  
2013	  
FusionMap	   RNA-­‐seq	  
data	  
Aligns	  fusion	  reads	  to	  
the	  genome	  without	  
prior	  knowledge	  of	  
probable	  fusion	  regions.	  
Can	  detect	  fusions	  from	  
single	  or	  paired-­‐end	  
reads.	  
Relies	  on	  long	  read	  lengths	  
and	  requires	  longer	  
computational	  time	  
compared	  to	  other	  methods.	  




In	  addition	  to	  detecting	  
gene	  fusions,	  this	  tool	  
constructs	  the	  
chimerical	  transcript	  
structures	  and	  estimates	  
their	  quantity.	  
Reports	  less	  gene	  fusions	  
compared	  to	  other	  methods	  
due	  to	  increased	  filter	  
constrictions.	  
Liu,	  Ma,	  Chang,	  




Ranks	  gene	  fusion	  
candidates	  by	  several	  
statistics	  and	  identifies	  
sequence	  at	  exact	  
breakpoints.	  
Fusion	  detection	  depends	  on	  
a	  gene	  annotation	  set	  for	  
information	  on	  genes	  and	  
their	  isoforms,	  so	  candidate	  
fusion	  identification	  is	  limited	  
to	  the	  set.	  





Table	  2:	  Descriptions	  of	  the	  selected	  databases	  of	  gene	  fusions	  
Database	   Content	   Number	  of	  
gene	  fusion	  
records	  
Website	   Reference	  





Kim	  et	  al.,	  
2010	  
COSMIC	   Gene	  fusions,	  
genomic	  
rearrangements,	  
and	  copy	  number	  
variations	  
9,054	   cancer.sanger.ac.uk/	   Forbes	  et	  
al.,	  2010	  



















Gene	   fusions	   are	   classified	   as	   drivers	   or	   passengers	   –	   drivers	   play	   an	   active	   role	   in	  
facilitating	  tumorigenesis	  while	  passengers	  do	  not.	  The	  pool	  of	  known	  gene	  fusions	  grows,	  and	  
there	   is	   strong	   demand	   to	   identify	   the	   gene	   fusions	   drivers	   for	   targeted	   studies.	   Research	  
groups	  put	   forth	   several	  approaches	   in	  attempt	   to	  accomplish	   this.	  Wang	  et	  al.	   (Wang	  et	  al.,	  
2009)	  published	  a	  method	  to	  predict	  a	  gene	  fusion’s	  driver	  likelihood	  with	  a	  ConSig	  score.	  The	  
ConSig	   score,	   derived	   from	   gene	   ontologies,	   assumes	   the	   driver	   probability	   for	   a	   gene	   is	  
correlated	  with	  the	  gene’s	  association	  to	  oncogenic-­‐related	  gene	  ontologies.	  The	  authors	  report	  
with	  low	  power	  that	  cancer-­‐related	  fusion	  genes	  share	  common	  gene	  ontologies.	  Shugay	  et	  el	  
(Shugay,	   Ortiz	   de	  Mendíbil,	   Vizmanos,	   &	   Novo,	   2013)	   developed	  Oncogene,	   an	   algorithm	   to	  
predict	   oncogenic	   potential	   of	   gene	   fusions	   based	   on	   known	   features	   in	   gene	   fusion	   drivers.	  
They	  focused	  on	  sequences	  including	  fusion	  protein	  domains	  and	  protein	  interaction	  interfaces	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to	  rank	  driver	  potential.	  They	  had	  positive	  results	  with	  validation	  tests,	  but	  they	  depend	  on	  the	  
current	   set	   of	   validated	   gene	   fusion	   drivers.	   Despite	   the	   algorithm	   development	   toward	  
classifying	  gene	  fusion	  drivers,	  we	  lack	  a	  robustly	  tested	  method	  with	  positive	  results.	  	  
Gene	  fusions	  drive	  an	  estimated	  20%	  of	  human	  cancer	  (Nambiar	  et	  al.,	  2008)	  and	  are	  of	  
great	  interest	  in	  cancer	  research	  and	  treatment.	  There	  is	  clinical	  success	  from	  translating	  BCR-­‐
ABL	   research	   into	   a	   usable	   drug	   and	   in	   diagnosing	   prostate	   cancer	   via	   targeted	   gene	   fusion	  
detection.	   There	   is	   room	   for	   improvement	   in	   methods	   for	   detecting	   gene	   fusions	   and	  
differentiating	   drivers	   from	   passengers.	   Additionally,	   there	   are	   knowledge	   gaps	   in	   what	   the	  
scientific	   community	   understands	   about	   gene	   fusions.	   It	   is	  mostly	   unclear	   how	   gene	   fusions	  
form.	  Radiation	  plays	  a	  role	  in	  gene	  fusion	  formation	  in	  papillary	  thyroid	  carcinomas	  (Mizuno,	  
Kyoizumi,	   Suzuki,	   Iwamoto,	   &	   Seyama,	   1997),	   and	   a	   handful	   of	   sequences	   common	   at	  
breakpoints	   in	   leukemia	   and	   lymphoma	   are	   reported	   (reviewed	   in	   (Aman,	   1999)).	   A	  
comprehensive	   study	   on	   where	   gene	   fusions	   form	   is	   lacking.	   Gene	   fusion	   research	   is	   in	   a	  
positive	  direction	  and,	  with	  enhanced	  sequencing	  technologies,	  continues	  to	  move	  forward.	  
1.2. Motifs	  and	  motif	  discovery	  
Motifs	  are	  short	  conserved	  sequences	  associated	  with	  biological	  functions.	  Among	  other	  
roles,	  motifs	   denote	   binding	   sites	   or	   splice	   junctions	   in	   DNA,	   and	   active	   sites	   or	   domains	   in	  
proteins.	  Type	   II	   restriction	  enzymes,	  which	  cut	  DNA	  in	  bacteria,	  must	  bind	  to	  specific	  motifs.	  
EcoRI	   binds	   to	   6-­‐mer	   5’-­‐GAATTC-­‐3’	   and	   incorrect	   binding	   leads	   to	   detrimental	   DNA	   shearing	  
(Pingoud	   &	   Jeltsch,	   2001).	   Motifs	   become	   more	   complicated	   with	   degenerative	   properties.	  
Escherichia	  coli	  require	  two	  conserved	  regions	  for	  transcription	  initiation:	  a	  “TATA	  box”	  10	  base	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pairs	   (bps)	   upstream	   and	   a	   TTGACA	   motif	   35	   bps	   downstream	   from	   the	   start	   site.	   Actual	  
transcription	  initiation	  sites	  match	  54-­‐82%	  (7-­‐9	  out	  of	  12	  base	  pairs)	  of	  these	  motifs	  (reviewed	  
in	   (D’haeseleer,	   2006)).	   Despite	   exchanged	   base	   pairs,	   transcription	   executes	   proving	   that	  
motifs	  do	  not	  always	  need	  to	  be	  exact	  sequences	  to	  be	  functional.	  
The	   scientific	   community	   uses	   sequence	   logos	   to	   represent	  motifs	   with	   degenerative	  
properties.	  A	  sequence	  logo	  is	  a	  position-­‐dependent	  symbol-­‐probability	  matrix	  –	  it	  depicts	  the	  
probability	  of	  possible	  symbols	  at	  each	  position	   in	  a	  graph.	  Figure	  1-­‐2	  shows	  a	  sequence	   logo	  
for	  repressor	  enzyme	  LexA’s	  binding	  motif.	  The	  y-­‐axis	  on	  the	  sequence	  logo	  represents	  “bits,”	  
which	  are	  binary	  digits	  with	  the	  information	  required	  to	  distinguish	  between	  two	  possibilities.	  
Two	  bits	  are	  required	  for	  the	  four	  nucleotides	  A,	  T,	  C	  and	  G	  (00,	  01,	  10,	  and	  11).	  Bits	  measure	  
the	  information	  content	  at	  a	  given	  position	  (Section	  1.3	  explains	  information	  content	  in	  detail).	  
A	   site	   with	   no	   sequence	   conservation	   will	   have	   0	   bits	   of	   information	   content,	   or	   an	   equal	  
chance	   of	   having	   A,	   T,	   C,	   or	   G.	   A	   completely	   conserved	   site	   will	   have	   2	   bits	   of	   information	  
content.	  The	  total	  information	  content	  at	  a	  position	  follows	  the	  equation	  2	  –	  the	  uncertainty	  of	  
that	  position,	  and	  the	  height	  of	  a	  symbol	  at	  that	  position	  is	  the	  information	  content	  multiplied	  
by	  the	  nucleotide’s	  relative	  frequency.	  
	  
Figure	  1-­‐2:	  Sequence	  logo	  representing	  LexA	  binding	  motif.	  On	  the	  y-­‐axis,	  “bits”	  is	  a	  measure	  of	  the	  relative	  base	  frequency	  
via	  information	  content.	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When	  an	  n-­‐mer	  repeats	  itself	  across	  polymer	  sequences,	  there	  is	  evidence	  that	  it	  does	  
not	   occur	   by	   chance	   and	  may	   be	   a	  motif.	   This	   is	   the	   basis	   for	  motif	   discovery.	   Identifying	   a	  
known	  motif	   in	  a	  sequence	  gives	  good	   indication	  on	  what	  biochemical	  process	  occurs	  at	   that	  
region.	   Identifying	  common	  motifs	  among	  sequences	  evinces	  that	   there	  are	  mutual	  biological	  
mechanisms	   acting	   at	   those	   regions.	   Motif	   discovery	   among	   sequences	   is	   a	   computational	  
process	   and	   there	   are	   three	  different	   categories	  of	  motif	   discovery	   algorithms:	   enumeration,	  
probabilistic	  optimization,	  and	  deterministic	  optimization	  (D’haeseleer,	  2006).	  
Enumerative	  motif	  discovery	  algorithms	  use	  exhaustive	  search	  on	  all	  possible	  motifs	  in	  a	  
search	  space	  (Sinha	  &	  Tompa,	  2002).	  An	  enumerative	  algorithm	  keeps	  a	  running	  total	  of	  n-­‐mer	  
occurrence	   in	   the	   target	   sequences,	   then	   reports	   those	   with	   the	   highest	   totals.	   Since	  
enumerative	  motif	  search	  is	  so	  thorough,	  these	  algorithms	  are	  not	  limited	  to	  a	  local	  optimum.	  
Nevertheless,	  restricting	  searches	  to	  exact	  nucleotide	  sequences	  may	  lead	  to	  overlooked	  actual	  
binding	  sites,	  which	  are	  often	  degenerate.	  These	  algorithms	  may	  miss	  flexible	  motifs.	  
Probabilistic	  optimization	  (or	  stochastic)	  algorithms	  depend	  on	  Gibbs	  sampling	  for	  motif	  
discovery.	   Gibbs	   sampling	   is	   sampling	   by	   one	   variable	   at	   a	   time	   conditioned	   on	   all	   other	  
variables.	  Probabilistic	  optimization	  algorithms	  work	  by	  sampling	  for	  motif	  start	  points,	  building	  
a	  position	  specific	  scoring	  matrix	  for	  all	  points	  excluding	  one,	  then	  setting	  the	  excluded	  point	  to	  
the	   position	   that	   best	   matches	   the	   matrix	   model	   (Thijs	   et	   al.,	   2002).	   The	   probability	   that	   a	  
symbol	  exists	  at	  a	  given	  position	  serves	  as	  a	  measure	  for	  sequence	  scores.	  Scores	  converge	  until	  
alignment	  no	  longer	  changes,	  resulting	  in	  a	  projected	  motif.	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Deterministic	   optimization	   algorithms	   depend	   on	   expectation	   maximization	   for	   motif	  
discovery.	   These	   algorithms	   iterate	   through	   two	   steps:	   the	   expectation	   step	   where	   current	  
parameters	   project	   an	   “expected”	   structure,	   and	   the	  maximization	   step	  where	   the	   expected	  
structure	   feeds	   back	   to	   re-­‐estimate	   parameters	   (Dempster,	   1977).	  Over	   iterations,	   the	   initial	  
structure	  converges	  to	  one	  with	  maximum	  log	   likelihood	   in	  the	  search	  space,	  and	  results	   in	  a	  
final	  motif.	  Expectation	  maximization	  is	  a	  local	  optimization	  –	  the	  final	  motif	  is	  sensitive	  to	  the	  
initial	   expected	   structure.	   Therefore,	   it	   does	   guarantee	   the	  model	   with	   global	  maximum	   log	  
likelihood	   for	   the	   search	   space	   (Blekas,	   Fotiadis,	   &	   Likas,	   2003).	   For	   optimization,	   one	   can	  
repeat	  these	  algorithms	  under	  different	  initial	  parameters	  to	  better	  chances	  of	  finding	  motifs.	  
Sequence	  data	  quality	   limits	   performance	   for	   each	  of	   these	  motif	   discovery	  methods.	  
For	  best	  results,	  one	  should	  restrict	  data	  to	  high-­‐quality	  sequences.	  It	  is	  important	  to	  consider	  
nucleotide	  background	  frequencies	  in	  the	  motif	  search	  space.	  Otherwise,	  most	  motif-­‐discovery	  
tools	   will	   assume	   equal	   probabilities	   for	   all	   nucleotides,	   skewing	   the	   motif’s	   statistical	  
significance	  measurements.	  
If	  motifs	  existed	  near	  gene	  fusion	  regions,	  they	  would	  help	  explain	  where	  and	  why	  gene	  
fusions	  happen,	   and	   improve	   the	  detection	  of	   gene	   fusions	   from	  complex	  data	   generated	  by	  
NGS.	   Gene	   fusion-­‐associated	   motifs	   may	   act	   as	   markers	   for	   fragile	   DNA	   regions	   or	   suggest	  
implication	  of	  a	  binding	  factor	  on	  gene	  fusion	  formation.	  Myers	  et	  al.	  (Myers,	  Freeman,	  Auton,	  
Donnelly,	  &	  McVean,	  2008)	  identified	  two	  sequence	  motifs	  associated	  with	  recombination	  hot	  
spots	   and	   genome	   instability:	   a	   7-­‐mer	   CCTCCCT	   and	   13-­‐mer	   CCNCCNTNNCCNC	   (“N”	   denotes	  
any	  base	  type).	  If	  these	  motifs	  are	  enriched	  near	  gene	  fusion	  breakpoints	  in	  cancers,	  we	  have	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evidence	   to	   predict	   cancer-­‐associated	   gene	   fusion	   formation	   results	   from	   aberrant	   crossover	  
events.	   Chmielecki	   et	   al.	   (Chmielecki	   et	   al.,	   2010)	   found	   that	   tyrosine-­‐kinase	   gene	   fusion	  
breakpoints	   occur	   upstream	   from	   a	   GXGXXG	   amino	   acid	   motif	   (“G”	   signifies	   glycine	   and	  	  
“X”	   signifies	   any	   amino	   acid).	   Finding	   a	   motif	   when	   limited	   to	   tyrosine-­‐kinase	   gene	   fusions	  
supports	   that	   gene-­‐fusion	   motifs	   are	   probable	   and	   performing	   motif	   discovery	   across	   many	  
cancer-­‐associated	  gene	  fusions	  may	  yield	  significant	  information.	  
After	  motif	  discovery	  and	  function	  identification,	  motifs	  are	  curated	  in	  public	  databases	  
like	  TRANSFAC	  (Matys	  et	  al.,	  2006)	  and	  JASPAR	  (Bryne	  et	  al.,	  2008).	  TRANSFAC	  (TRANScription	  
FACtor	  database)	  contains	  information	  on	  eukaryotic	  transcription	  factors	  with	  their	  respective	  
genomic	   binding	   sites	   and	  DNA	  binding	   profiles.	   The	   database	   offers	   tools	   to	   facilitate	  motif	  
based	   research.	  Match	   is	   a	   weight	   matrix-­‐based	   program	   that	   predicts	   transcription	   factor	  
binding	   sites	   from	   their	  database	   in	  DNA	   sequences.	  F-­‐Match	   builds	  off	  Match	   and	   identifies	  
statistically	  over-­‐represented	  transcription	  factor	  binding	  sites	  in	  a	  set	  of	  sequences	  compared	  
against	  a	  control	  sequence	  set.	  If	  a	  known	  binding	  factor	  is	  implicated	  in	  gene-­‐fusion	  formation,	  
it	  will	  have	  enriched	  binding	  sites	  near	  breakpoints	  that	  form	  fusions.	  F-­‐Match	  is	  an	  appropriate	  
tool	  to	  identify	  those	  binding	  sites	  and	  evince	  differences	  compared	  to	  control	  sequences.	  
1.3. DNA	  entropy	  
Entropy	  measures	  the	  number	  of	  ways	  a	  thermodynamic	  system	  can	  be	  arranged	  and	  is	  
commonly	  thought	  of	  as	  a	  gauge	  for	  disorder	  and	  uncertainty.	  Entropy	   is	   inversely	  correlated	  
with	   information	   content,	   making	   information	   content	   a	   measure	   of	   certainty.	   The	   base	   of	  
these	  measurements	  requires	  determining	  the	  number	  of	  binary	  decisions	  required	  to	  ascertain	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information.	  The	   formula	   for	  determining	   the	  number	  of	  binary	  decisions	   (𝑛𝑞)	   for	  a	   set	  of	  𝑁	  
options	  is:	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  𝑛𝑞 = 𝑙𝑜𝑔2𝑁	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  (	  1	  )	  
As	   a	   simple	   example,	   imagine	   the	   set	   for	   four	   nucleotides	   {A,	   C,	   T,	   G}	   where	   one	  
nucleotide	   is	   selected	   and	   a	   person	   must	   determine	   which	   nucleotide	   it	   is	   using	   binary	  
questions.	  The	  person	  may	  probe	  if	  the	  nucleotide	  is	  in	  the	  set	  {A,	  C},	  then	  further	  reduce	  the	  
set	  into	  single	  nucleotides.  𝐿𝑜𝑔24 = 2	  questions	  are	  needed	  to	  determine	  the	  nucleotide.	  This	  
equation	  assumes	   the	  probability	   for	   all	   elements	  of	   the	   set	   are	  equal.	  When	  elements	  have	  
disparate	  probabilities,	  we	  can	  gauge	  aberrancy	  for	  a	  element’s	  occurrence	  with	  the	  expanded	  
equation	   below,	   where	  ℎ𝑖  signifies	   aberrancy	   from	   seeing	   that	   element,	   and	  𝑝𝑖	   signifies	   the	  
element’s	  probability	  for	  occurrence	  (Schneider,	  Stormo,	  Gold,	  &	  Ehrenfeucht,	  1986).	  Figure	  1-­‐3	  
shows	  the	  aberrancy	  curve	  h	  for	  element	  probabilities	  in	  the	  range	  0	  to	  1.	  




Figure	  1-­‐3:	  A	  curve	  showing	  the	  measure	  of	  aberrancy	  (h)	  for	  element	  probabilities	  in	  the	  range	  0	  to	  1,	  as	  calculated	  from	  
equation	  2.	  	  
Claude	   Shannon	   coined	   the	   “uncertainty	  measure,”	   or	   Shannon	   Entropy,	  which	   is	   the	  
average	  aberrancies	  weighted	  by	  their	  occurrence	  probability.	  Shannon	  entropy	  is	  calculated	  by	  
the	  equation	  below	  (C.	  E.	  Shannon,	  2001).	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  𝐻 =    𝑝𝑖ℎ𝑖! =   − 𝑝𝑖𝑙𝑜𝑔2𝑝𝑖! 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  (	  3	  )	  
Schneider	   defines	   information	   content,	   based	   on	   Shannon’s	   uncertainty,	   as	   the	  
difference	   in	   global	   uncertainty	   and	   uncertainty	   at	   a	   given	   position	   (j),	   calculated	   by	   the	  
equation	  below	  (Schneider	  et	  al.,	  1986).	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  𝐼𝐶𝑗 = 𝐻𝑔 − 𝐻𝑗	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  (	  4	  )	  
Entropy	   estimates	   on	   DNA	   provide	   information	   about	   genomic	   complexity	   and	  
arrangement.	  Fragments	  of	  DNA	  under	  selective	  pressure	  have	  lower	  entropy	  than	  those	  that	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are	   not	   –	   exons	   have	   lower	   entropy	   than	   introns	   and	   older	   fragments	   of	   DNA	   have	   lower	  
entropy	   than	  younger	   (Koslicki,	   2011).	   Farach	  et	   al.	   used	  entropy	  measurements	  as	   a	  way	   to	  
detect	  DNA	  splice	  junctions	  (Farach	  et	  al.,	  1995).	  A	  second	  way	  to	  think	  of	  Shannon	  entropy	  is	  a	  
measure	  for	  how	  efficiently	  data	  could	  be	  compressed	  without	  loss.	  Higher	  the	  entropy	  means	  
less	  redundancy	  and	  lesser	  compression.	  Gatlin	  proposes	  that	  high	  redundancy	  DNA	  molecules	  
with	  optimum	  composition	  may	  have	  lower	  probability	  of	  error,	  therefore	  it	  is	  appropriate	  that	  
exons	  and	  conserved	  regions	  have	  lower	  entropy	  (Gatlin,	  1968).	  
A	   sliding	   window	   entropy	   analysis	   reveals	   changes	   in	   complexity	   throughout	   a	   DNA	  
sequence.	   The	   sliding	  window	  works	   by	   setting	   a	   frame	   length	   and	   start	   position	   on	   a	   DNA	  
sequence.	  The	  region	  within	  the	  frame	  yields	  a	  Shannon	  entropy	  measure,	  which	   is	  recorded,	  
then	   the	   frame	   shifts	   a	   determined	   number	   of	   base	   pairs	   downstream	   and	   another	   read	   is	  
taken.	  Once	  graphed,	  the	  entropy	  measures	  show	  changes,	  oscillations,	  and	  conserved	  regions	  
that	  describe	   the	  sequence.	  Performed	  at	  gene	   fusion	  breakpoints,	  we	  can	  gauge	  patterns	   in	  
entropy	   that	   may	   help	   explain	   where	   gene	   fusions	   happen	   and	   why.	   We	   hypothesize	   an	  
entropy	  increase	  at	  breakpoint	  regions	  that	  signifies	  higher	  probability	  for	  error.	  	  
1.4. Network	  analysis	  
A	  network	  is	  a	  graphical	  representation	  of	  data	  that	  consists	  of	  nodes,	  which	  represent	  
entities,	   and	   edges,	  which	   represent	   relationships.	   A	   network	   can	   be	   directed	   or	   undirected.	  
Directed	  networks	  have	  edges	  that	  are	  one	  way	  denoting	  X	  acts	  on	  Y	  but	  Y	  does	  not	  act	  on	  X.	  
An	  example	  of	  a	  directed	  network	  is	  a	  food	  chain	  –	  a	  fox	  eats	  the	  rabbit	  and	  the	  rabbit	  does	  not	  
eat	   the	   fox.	  Undirected	   networks	   denote	  mutual	   relationships.	   An	   example	   of	   an	   undirected	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network	  is	  a	  social	  network	  –	  Anne	  is	  friends	  with	  Beth	  therefore	  Beth	  is	  friends	  with	  Anne.	  To	  
differentiate	   between	   the	   two	   graphically,	   directed	   networks	   have	   arrows	   for	   edges	   while	  
undirected	  networks	  have	  lines	  Figure	  1-­‐4.	  
Directed	  Network	   Undirected	  Network	  
	   	  
Figure	  1-­‐4:	  Illustrations	  of	  directed	  and	  undirected	  networks.	  
A	  mathematical	  descriptor	  of	  nodes	  is	  centrality,	  a	  measure	  of	  weight	  or	  importance	  in	  a	  
network.	   There	   are	   three	   categories	  of	   centrality:	   degree	   centrality,	   closeness	   centrality,	   and	  
betweenness	  centrality.	  
Degree	  centrality	  is	  based	  on	  the	  node’s	  degree,	  which	  is	  the	  number	  of	  connections,	  or	  
edges,	  it	  has	  to	  other	  nodes.	  In	  directed	  networks,	  degree	  is	  categorized	  by	  in-­‐degree	  and	  out-­‐
degree	  (the	  number	  of	  edges	  directed	  away	  from	  the	  node	  and	  the	  number	  of	  edges	  directed	  
toward	  it.	  A	  node’s	  degree	  centrality	  can	  be	  interpreted	  as	  the	  probability	  of	  intercepting	  that	  
node	  when	  moving	  through	  the	  network.	  
Closeness	  centrality	  is	  a	  measure	  for	  how	  easily	  one	  can	  move	  to	  the	  rest	  of	  the	  network	  
from	  the	  given	  node.	  The	  lowest	  number	  of	  edges	  that	  need	  to	  be	  traversed	  to	  reach	  one	  node	  
from	  another	  defines	  their	  distance.	  The	  “farness”	  of	  a	  node	  is	  the	  sum	  of	  its	  distances	  to	  all	  of	  
the	  other	  nodes,	  and	  its	  “closeness”	  is	  the	  inverse	  of	  the	  “farness”	  (Sabidussi,	  1966).	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Betweenness	  centrality	   is	   the	  total	  number	  of	   times	  a	  node	  acts	  as	  a	  bridge	  along	  the	  
shortest	  path	  between	  two	  other	  nodes.	  It	  is	  interpreted	  as	  a	  measure	  for	  control	  of	  movement	  
through	   the	  network	   (Freeman,	   1977).	  Nodes	  with	   high	  betweenness	   have	   regulatory	   power	  
over	  information	  flow	  through	  the	  network.	  
Networks	   are	   classified	   by	   their	   degree	   distribution	   (Figure	   1-­‐5).	   Random	   networks	  
manifest	   a	  normal	   degree	  distribution	  –	   the	  degrees	  of	   all	   nodes	   are	  distributed	  around	  and	  
average.	  Scale-­‐free	  networks	  manifest	  a	  power-­‐law	  distribution	  in	  which	  most	  nodes	  have	  low	  
degrees	  and	  a	   few	  nodes	  have	  high	  degrees.	  When	  observing	  any	  sub-­‐region	  of	   the	  network,	  
the	  degree	  distribution	  will	  always	  follow	  the	  power-­‐law,	  hence	  the	  name	  scale-­‐free.	  Biological	  
networks,	  such	  as	  those	  that	  depict	  gene	  regulation	  and	  signaling	  are	  scale-­‐free	  (Albert,	  2005).	  
Höglund	  et	   al.	   built	   the	   first	   gene	   fusion	  network	  where	  nodes	   represent	  participating	   genes	  
and	   edges	   represent	   a	   gene	   fusion	   event.	   They	   reported	   that	   the	   network’s	   organization	  
demonstrates	  a	  scale-­‐free	  network	   topology	  with	   the	  power	   law	  degree	  distribution	   found	   in	  
naturally	  occurring	  networks	  (Höglund,	  Frigyesi,	  &	  Mitelman,	  2006).	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Random	  Undirected	  Network	   Scale-­‐free	  Undirected	  Network	  
	  
	  
	   	  
Figure	  1-­‐5:	  Example	  of	  a	  random	  network	  and	  its	  degree	  distribution	  (left	  column)	  and	  a	  real	  (or	  scale-­‐free)	  network	  and	  its	  
degree	  distribution	  (right	  column).	  
	  
Protein-­‐protein	  interaction	  (PPI)	  networks	  reflect	  functional	  interactions	  such	  as	  cellular	  
pathways	  –	  nodes	  represent	  proteins	  and	  edges	  denote	  interactions	  with	  other	  proteins.	  A	  PPI	  
network	   depicts	   which	   proteins	   interact,	   which	   protein	   groups	   are	   modular,	   and	   where	  
feedback	   loops	   occur.	  Wu	   et	   al.	   (Wu,	   Kannan,	   Lin,	   Yen,	  &	  Milosavljevic,	   2013)	  mapped	   gene	  
fusions	  to	  a	  PPI	  network	  for	  the	  purpose	  of	  highlighting	  gene	  fusion	  drivers.	  They	  hypothesized	  
that	  a	  gene	  fusion	  is	  more	  likely	  to	  be	  a	  driver	  if	  one	  or	  more	  participating	  genes	  act	  as	  a	  hub	  in	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a	   PPI	   network.	   The	   more	   connected	   a	   gene	   is,	   the	   more	   deregulation	   it	   would	   cause	   if	  
disrupted.	   Their	   study	   used	   data	   on	   known	   cancer	   fusions	   from	   the	   Cancer	   Gene	   Census	  
database	  (Futreal	  et	  al.,	  2004)	  and	  their	  method	  correctly	  predicted	  most	  of	  the	  38	  fusions	  with	  
oncogenic	  importance	  in	  their	  test	  set	  (with	  19%	  false	  positive	  rate).	  
We	  chose	  to	  explore	  the	  role	  gene	  fusions	  have	   in	  cancer	  and	  their	   impact	  on	  cellular	  
pathways	  with	  network	  analysis.	  We	  tested	  the	  hypothesis	  that	  gene	  fusions	  in	  cancer	  are	  more	  
disruptive	   compared	   to	   passive	   mutations	   by	   comparing	   network	   metrics	   across	   true	   gene	  
fusions	   and	   randomly	   generated	   gene	   fusions.	   We	   used	   two-­‐gene	   gene	   fusion	   data	   from	  
COSMIC	   and	   randomly	   generated	   gene	   fusion	   sets.	   After	   mapping	   fusion	   genes	   in	   the	   PPI	  













2.1. Data	  Sources	  
All	  gene	  fusion	  records	  were	  collected	  from	  the	  Catalog	  of	  Somatic	  Mutations	  in	  Cancer	  
(COSMIC)	   (http://cancer.sanger.ac.uk/cancergenome/projects/cosmic/download)	   (Forbes	   et	  
al.,	   2010).	   COSMIC	   is	   a	   public	   database	   for	   information	   on	   gene	   fusions,	   genomic	  
rearrangements,	   and	   copy	   number	   variations	   in	   human	   cancers.	   The	   database	   curates	  
mutations	   reported	   in	   scientific	   literature,	   and	  mutations	   reported	   from	   the	  Cancer	  Genome	  
Project	   (CGP)	   at	   the	   Sanger	   Institute	  UK.	   Table	   3	   shows	   general	   statistics	   on	   COSMIC’s	   gene	  
fusion	   dataset	   as	   of	   the	   date	   7/25/2013.	   Figure	   0-­‐1	   shows	   the	   chromosomal	   distribution	   of	  
genes	   participating	   in	   fusions	   for	   our	   dataset,	   and	   Figure	   0-­‐2	   shows	   the	   distribution	   by	   the	  
primary	  tissue	  type	  that	  the	  gene	  fusions	  were	  reported	  from.	  
Table	  3:	  	  An	  overview	  of	  the	  gene	  fusion	  data	  deposited	  in	  COSMIC	  database	  as	  of	  7/25/2013	  
Number	  of	  reported	  gene	  fusions	   9054	  
Number	  of	  gene	  fusions	  with	  sequence	  data	   662	  
Number	  of	  participating	  genes	   222	  
Number	  of	  unique	  gene	  pairs	   200	  





Figure	  0-­‐1:	  The	  distribution	  by	  chromosome	  position	  for	  the	  COSMIC	  reported	  genes	  participating	  in	  fusions.	  
	  






























We	   filtered	   the	   gene	   fusion	   dataset	   for	   records	   with	   5’	   and	   3’	   gene	   names,	   mRNA	  
transcripts,	   and	   first/last	   transcript	   nucleotide	   numbers.	  We	   excluded	   fusions	   involving	  more	  
than	   two	   genes	   and	   those	   with	   additional	   insertion	   or	   deletion	   sequences.	   In	   Table	   3,	   the	  
number	   of	   unique	   sequences	   is	   higher	   than	   that	   of	   the	   unique	   gene	   pairs	   because,	   in	   some	  
cases,	  a	   fusion	  pair	  exhibits	  different	  breakpoints.	  Sequence	  data	   is	   from	  the	  human	  genome	  
reference	   37.72,	   which	   we	   downloaded	   from	   Ensembl	   (ftp://ftp.ensembl.org/pub/release-­‐
72/fasta/homo_sapiens/dna/)	   (Flicek	   et	   al.,	   2014).	   The	   protein-­‐protein	   interaction	   network	  
data	  comes	  from	  PINA:	  Protein	  Interaction	  Network	  Analysis	  version	  2	  (Cowley	  et	  al.,	  2012).	  
2.2. Software	  and	  Tools	  
All	   data	   processing	   was	   performed	   with	   programming	   languages	   Perl	   and	   R.	   Motif	  
discovery	   was	   performed	   with	   Multiple	   EM	   for	   Motif	   Elicitation	   (MEME)	   version	   4.9.0	  
(http://ebi.edu.au/ftp/software/MEME/4.9.0/)	  (Bailey	  et	  al.,	  2009).	  We	  chose	  this	  tool	  because	  
it	  uses	  a	  deterministic	  optimization	  algorithm	  –	  it	  does	  not	  require	  a	  motif	  to	  exist	  in	  each	  input	  
sequence	  and	  it	  determines	  likely	  motif	  lengths	  for	  the	  user	  (which	  is	  helpful	  when	  there	  are	  no	  
a	   priori	   assumptions	   about	   potential	   motifs).	   We	   used	   TRANSFAC	   F-­‐Match	   to	   search	   for	  
statistically	   over-­‐represented	   binding	   sites	   near	   breakpoints	   that	   form	   fusions	   (Matys	   et	   al.,	  
2006).	   The	   network	   analysis	  was	   performed	  with	   the	   network	   construction	   and	   visualization	  
software,	   Cytoscape	   (P.	   Shannon	   et	   al.,	   2003).	   Network	   statistics	   were	   calculated	   using	   the	  
Cytoscape	   plug-­‐in	   CentiScaPe	   (Scardoni,	   Petterlini,	   &	   Laudanna,	   2009).	   The	   list	   of	   known	  
protein-­‐protein	  interactions	  was	  downloaded	  from	  PINA:	  Protein	  Interaction	  Network	  Analysis	  
Platform	  version	  2	  (http://cbg.garvan.unsw.edu.au/pina/download/)	  (Cowley	  et	  al.,	  2012).	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2.3. Gene	  fusion	  motif	  discovery	  
The	  goal	   for	  motif	  discovery	   in	   this	   study	   is	   to	   identify	  motifs	  enriched	  at	  gene	   fusion	  
breakpoints,	  which	   help	   explain	  where	   they	   occur	   and	  why.	   The	   results	  may	   further	   help	   us	  
predict	   novel	   fusion	   breakpoints	   in	   future.	  We	   performed	   in	   silico	   motif	   discovery	   on	   gene-­‐
fusion	  breakpoint	  sequences	  and	  compared	  results	  to	  motifs	  found	  at	  recombination	  hot	  spots	  
and	  motifs	  identified	  by	  transcription	  factor	  binding	  sites.	  
To	   perform	   motif	   discovery	   on	   gene	   fusion	   breakpoints,	   it	   is	   necessary	   to	   know	   the	  
nucleotide	   position	   on	   the	   genome	   where	   the	   break	   has	   occurred.	   Gene	   fusion	   data	   was	  
collected	   from	  mRNA	   transcripts	   where	   introns	   were	   removed.	   If,	   upon	  mapping	   the	  mRNA	  
transcripts	  back	  to	  the	  genome,	  we	  find	  that	  the	  breakpoint	  occurred	  within	  an	  exon,	  we	  know	  
the	   exact	   position	   for	   the	   breakpoint.	   Otherwise,	   if	   we	   find	   that	   the	   breakpoint	   happened	  
between	  two	  exons,	  we	  only	  know	  the	   intron	  region	   in	  which	   the	  breakpoint	  occurred.	  Since	  
intron	  regions	  can	  be	  long,	  we	  did	  not	  find	  it	  appropriate	  to	  compare	  them	  to	  specific	  regions	  
symmetric	   around	   an	   exonic	   breakpoint.	   Therefore,	   intron-­‐region	  breakpoints	  were	   excluded	  
from	   this	   study.	   It	   is	   more	   likely	   that	   gene	   fusions	   occur	   in	   intronic	   regions	   than	   in	   exonic	  
regions	  –	  breakpoints	  in	  transcribed	  areas	  may	  be	  more	  disruptive	  and	  selected	  against.	  Gene-­‐
fusion	   discovery	  methods	   bias	   toward	   finding	   fusion	   with	   exonic	   breakpoints	   since	   they	   are	  
easier	   to	  detect	   in	  mRNA	  transcripts.	  After	   filtering	   for	  exon-­‐region	  breakpoints,	  we	  removed	  
repeats	  and	  close-­‐range	  breakpoints	  (those	  that	  exist	  more	  proximal	  to	  a	  breakpoint	  than	  the	  
range	   of	   our	   desired	   excerpt	   length).	   Our	   input	   consisted	   of	   142	   genomic	   breakpoints	   that	  
formed	  gene	  fusions.	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Since	  some	  regulators	  act	  on	  regions	  several	  hundred	  base	  pairs	  away	  from	  where	  they	  
bind,	   we	   strove	   to	   make	   our	   search	   space	   as	   wide	   as	   possible.	   One	   limiting	   factor	   was	  
computational	  power.	  We	  found	  the	  maximum	  capacity	  for	  MEME	  with	  142	  input	  sequences	  is	  
approximately	  600	  base	  pairs	  per	  sequence.	  Therefore,	  we	  extracted	  600	  base	  pair	  regions	  of	  
genomic	   DNA	   centered	   on	   gene	   fusion	   breakpoints	   to	   serve	   as	   input.	   We	   want	   to	   uncover	  
motifs	  that	  exist	  in	  a	  subset	  of	  gene	  fusions,	  which	  requires	  motif	  output	  beyond	  that	  of	  most	  
statistical	   significance	   in	   the	  whole	   dataset.	   For	   this	   reason,	  we	   also	   extracted	  300	  base	  pair	  
regions	  for	  input.	  
In	  our	  MEME	  command,	  we	  specified	  that	  sequences	  have	  zero	  or	  one	  occurrence	  of	  a	  
given	  motif,	  that	  motifs	  may	  occur	  on	  the	  provided	  DNA	  strand	  or	  its	  reverse	  compliment,	  and	  
that	  the	  maximum	  motif	   length	  could	  be	  20	  base	  pairs	  (longer	  than	  the	  previously	  mentioned	  
recombination	  hot	  spot	  motifs).	  MEME	  produced	  all	  summary	  statistics	  and	  graphs	  used	  in	  our	  
analysis.	  We	  were	  most	   interested	   in	  motif	   E-­‐values,	   which	   is	   an	   estimate	   for	   the	   expected	  
number	  of	  motifs	  with	  its	  log	  likelihood	  ratio	  or	  higher	  that	  would	  exist	  in	  a	  like	  set	  of	  random	  
sequences.	  Lower	  e-­‐values	  denote	  greater	  significance.	  We	  also	  examined	  the	  position	  of	   the	  
motifs	   within	   the	   sequences	   to	   determine	   position	   patterns	   (i.e.	   a	   given	  motif	   always	   exists	  
upstream	  from	  breakpoint	  opposed	  to	  downstream).	  
Next,	  we	  chose	   to	   search	   for	   known	   transcription	   factor	  binding	   sites	  with	   the	  aim	  of	  
uncovering	   enrichment	   at	   breakpoints	   that	   form	   fusions.	   Motif	   discovery	   should	   report	  
enriched	  sites	  and	  obviate	  a	  targeted	  search,	  but	  the	  targeted	  search	  is	  beneficial	  in	  that	  it	  has	  
much	   less	   probability	   for	   type	   II	   error.	   The	   targeted	   search	   is	   restricted	   to	   confirmed	  motifs	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rather	   than	  motifs	   falling	  within	   a	   set	   or	   parameters.	   There	   is	   greater	   sensitivity	   for	   spotting	  
those	  motifs,	  which	  is	  favorable	  in	  the	  event	  that	  motif	  discovery	  misses	  sequences	  with	  global	  
maximum	   log	   likelihood.	   Of	   course,	   since	   the	   targeted	   search	   is	   restricted	   to	   known	  
transcription	   factor	   binding	   sites,	   motif	   discovery	   remains	   beneficial	   when	   undocumented	  
motifs	  exist.	  We	  used	  TRANSFAC’s	  F-­‐Match	  for	  the	  targeted	  search.	  Our	  input	  files	  included	  the	  
breakpoint-­‐centered	  600	  base	  pair	  sequences,	  plus	  600	  base	  pair	  control	  sequences	  centered	  at	  
random	  exonic	  nucleotides	  within	  our	  gene	  set.	  We	  were	  interested	  in	  over	  represented	  sites	  
with	  p-­‐values	  less	  than	  0.05.	  
2.4. Gene	  fusion	  entropy	  analysis	  
For	   the	   entropy	   analysis,	   we	   used	   142	   sequences	   of	   600	   base	   pairs	   centered	   at	  
breakpoints	   that	   form	  gene	   fusions.	  These	  are	   the	  same	  sequences	  used	   in	  motif	  discovery	  –	  
non-­‐repeating,	   non-­‐overlapping,	   exonic	   breakpoints.	   We	   also	   used	   142	   control	   sequences	  
centered	  at	  random	  exonic	  breakpoints.	  We	  wrote	  a	  Perl	  program	  to	  set	  up	  the	  sliding	  frame	  
and	  calculate	  entropies.	  We	  chose	  to	  take	  measurements	  in	  20	  base	  pair	  frames	  and	  shifted	  5	  
base	  pairs	  with	  each	  measurement.	  Then,	  split	  by	   test	  and	  control,	  we	  averaged	  the	  reads	   in	  
the	   same	   frame	   positions	   and	   plotted	   measurements	   on	   a	   line	   graph.	   We	   calculated	   local	  
maximum	  and	  minimum	  reads	  and	  compared	  across	  the	  test	  and	  control	  set.	  
2.5. Gene	  fusion	  network	  analysis	  
We	  collected	  all	  gene	  fusion	  entries	  with	  5’	  and	  3’	  genes	  from	  the	  COSMIC.	  Unlike	  the	  
motif	   discovery	   and	   entropy	   analysis,	   this	   study	   does	   not	   require	   sequence	   data	   so	   records	  
without	  specific	  sequence	  data	  were	  included.	  Each	  unique	  gene	  fusion	  is	  represented	  once	  in	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the	  network	  and	  there	  are	  200	  fusions	  pairs	  with	  222	  unique	  genes	  participating	  in	  fusions.	  We	  
generated	  a	   control	  gene	   fusion	  dataset	   that	   complements	  our	   test	   set	  with	  200	   fusions	  and	  
222	  unique	  genes	  by	  randomly	  sampling	  a	  list	  of	  all	  human	  genes.	  
We	  mapped	  the	  genes	  participating	  in	  fusions	  (in	  both	  the	  test	  and	  control	  data	  sets)	  to	  
their	   respective	   proteins	   in	   a	   protein-­‐protein	   interaction	   network	   and	   extracted	   all	   first-­‐
neighbor	  proteins.	  Then	  we	  built	  network	  files	  where	  each	  gene	  fusion	  is	  assigned	  a	  node	  and	  
that	  node	   is	  connected	  to	  the	  union	  of	  proteins	  that	   interact	  with	  the	  5’	  and	  3’	   fusion	  genes.	  
We	  used	  Cytoscape	  (P.	  Shannon	  et	  al.,	  2003)	  to	  visualize	  the	  networks	  and	  the	  Cytoscape	  plug-­‐
in	  CentiScaPe	  (Scardoni	  et	  al.,	  2009)	  to	  calculate	  degree	  for	  all	  of	  the	  nodes.	  We	  compared	  the	  














3.1. Gene	  fusion	  motif	  discovery	  
The	   letter	   frequencies	   for	   the	   600	   base	   pair	   sequences	   input	   file	   is	   0.283	  A,	   0.217	   C,	  
0.217	   G,	   and	   0.283	   T.	   These	   proportions	   served	   as	   the	   base	   frequencies	   for	   calculating	  
significance	  for	  motifs	   in	  this	  dataset.	  Table	  4	  displays	  the	  motif	  output	   for	   the	  600	  base	  pair	  
sequence	  file.	  Each	  of	  the	  four	  motifs	  are	  highly	  significant	  (e-­‐value	  less	  than	  0.05)	  but	  contain	  
the	  maximum	  number	  of	  base	  pairs	  allotted.	  Motif	  number	  600-­‐4	  has	  maximum	  conservation	  
for	   G	   at	   nucleotides	   five	   and	   eight.	   Density	   maps	   of	   the	   motif	   sequence	   positions	   show	  
homogenous	   distribution	   –	   there	   is	   no	   sharp	   skew	  upstream,	   downstream,	   or	   in	   a	   particular	  
range	  for	  any	  of	  the	  four	  motif	  positions	  on	  the	  sequences	  (shown	  in	  Figure	  0-­‐1).	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Table	  4:	  Details	  on	  motifs	  found	  within	  600	  base-­‐pair	  regions	  of	  breakpoints	  that	  form	  gene	  fusions.	  




































Figure	   0-­‐1:	   Density	   plot	   for	   the	   start	   positions	   of	   motifs	   found	   in	   the	   600	   base	   pair	   breakpoint	   sequences.	   The	   x-­‐axis	  
represents	  nucleotide	  position	  and	  breakpoints	  occur	  in	  the	  center	  at	  300	  base	  pairs.	  
The	   letter	   frequencies	   for	   the	   300	   base	   pair	   sequences	   input	   file	   is	   0.279	  A,	   0.221	   C,	  
0.221	   G,	   and	   0.279	   T.	   These	   proportions	   served	   as	   the	   base	   frequencies	   for	   calculating	  
significance	   for	  motifs	   in	   this	  dataset.	   Table	  5	  displays	   the	   significant	   (e-­‐value	   less	   than	  0.05)	  
motifs	  for	  the	  300	  base	  pair	  sequence	  file.	  Like	  results	  in	  the	  600	  base	  pair	  input	  file,	  all	  motifs	  
are	   at	   the	   maximum	   20	   base	   pairs	   in	   length	   and	   the	   motif-­‐sequence	   position	   maps	   show	  
homogenous	  distribution	   for	  all	  motifs	   (shown	   in	  Figure	  0-­‐2).	  Motif	  number	  600-­‐1	  and	  300-­‐2	  
are	  similar	   in	  that	  they	  are	  T-­‐rich.	  However,	  other	  motifs	  from	  the	  two	  input	  files	  matched	  at	  
high	  information	  content	  positions	  even	  though	  they	  have	  overlapping	  e-­‐values.	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Table	  5:	  Details	  on	  motifs	  found	  within	  300	  base-­‐pair	  regions	  of	  breakpoints	  that	  form	  gene	  fusions.	  



































Figure	   0-­‐2:	   Density	   plot	   for	   the	   start	   positions	   of	   motifs	   found	   in	   the	   300	   base	   pair	   breakpoint	   sequences.	   The	   x-­‐axis	  
represents	  nucleotide	  position	  and	  breakpoints	  occur	  in	  the	  center	  at	  150	  base	  pairs.	  
The	   transcription	   factor	   binding	   site	   search	   by	   F-­‐Match	   identified	   three	   sites	   over-­‐
represented	  in	  breakpoint	  regions	  that	  form	  gene	  fusions.	  Table	  6	  lists	  the	  sites	  with	  their	  test	  
to	  control	  ratios	  and	  p-­‐values.	  Each	  of	  the	  three	  sites	  had	  statistically	  significant	  p-­‐values	  (less	  
than	  0.05).	  
Table	  6:	  Over-­‐represented	  transcription	  factor	  binding	  sites	  in	  600	  base	  pair	  regions	  centered	  at	  breakpoints	  that	  form	  gene	  
fusions	  compared	  to	  control	  sequences	  
Matrix	  Identifier	  	   Name	   Ratio	  (Test	  :	  
Control)	  
P-­‐value	  
V$MINI19_B	   Muscle	  initiator	  
sequences-­‐19	  
3.12	  	   6.72e-­‐4	  	  
V$TATA_01	   TATA	  Box	   1.46	   4.35e-­‐4	  	  




3.2. Gene	  fusion	  entropy	  analysis	  
Figure	   0-­‐3	   graphs	   the	   average	   entropy	   reads	   with	   standard	   error	   for	   142	   sequences	  
centered	   at	   gene-­‐fusion	   breakpoints.	   On	   average,	   the	   standard	   deviation	   is	   10.4%	   of	   the	  
entropy.	  The	  red	  portion	  of	  line	  represents	  reads	  the	  overlap	  breakpoints.	  The	  break	  occurs	  in	  a	  
local	  high	  entropy	  area	  followed	  by	  a	  local	  low	  entropy	  area.	  Figure	  0-­‐4	  graphs	  average	  entropy	  
reads	  with	  standard	  error	   for	  142	  control	   sequences	  centered	  at	   random	  exonic	  breakpoints.	  
On	  average,	  the	  standard	  deviation	  is	  10.7%	  of	  the	  entropy.	  The	  red	  portion	  of	  line	  represents	  
reads	  the	  overlap	  random	  breakpoints.	  Table	  7	  lists	  the	  maximum	  and	  minimum	  entropy	  reads	  
for	   the	   test	   and	   control	   sets	   with	   their	   p-­‐values	   from	   t-­‐tests.	   The	   distance	   between	   the	  
maximum	  and	  minimum	  average	  entropies	   is	  approximately	  45	  base	  pairs	   in	   the	   test	   set	  and	  
320	  base	  pairs	  in	  the	  control	  set.	  The	  largest	  percent	  change	  in	  the	  test	  set	  is	  17.29%	  over	  45	  




Figure	  0-­‐3:	  Average	  entropy	  values	  across	  600	  base	  pair	  sequences	  centered	  at	  gene	  fusion	  breakpoints.	  Reads	  are	  in	  20	  base	  
pair	  frames	  with	  5	  bases	  per	  shift.	  The	  red	  fragment	  of	  line	  represents	  reads	  overlapping	  the	  breakpoints.	  
	  
Figure	  0-­‐4:	  Average	  entropy	  values	  across	  600	  base	  pair	  control	  sequences	  centered	  at	  random	  exonic	  breakpoints.	  Reads	  are	  
in	  20	  base	  pair	  frames	  with	  5	  bases	  per	  shift.	  The	  red	  fragment	  of	  line	  represents	  reads	  overlapping	  the	  random	  breakpoints.	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Table	  7:	  The	  maximum	  and	  minimum	  average	  entropy	  reads	  for	  test	  and	  control	  sequences	  with	  p-­‐values	  from	  t-­‐tests.	  
	   Test	   Control	   p-­‐value	  
Max	  H	   1.819	   1.822	   0.88	  
Min	  H	   1.710	   1.729	   0.55	  
p-­‐value	   0.0004	   0.0001	   	  
	  
3.3. Gene	  fusion	  network	  analysis	  
The	   gene	   fusion	   network	   is	   very	   large	   with	   2,941	   nodes	   and	   14,812	   edges.	   It	   is	   too	  
complex	   to	   illustrate	   in	  a	   figure	  here.	  The	  degree	  distribution	   for	   the	  overall	  network	   follows	  
the	  power-­‐law	  (Figure	  0-­‐5)	  as	  does	  the	  degree	  distribution	  for	  only	  the	  nodes	  representing	  gene	  
fusions	  (Figure	  0-­‐6).	  These	  results	  match	  those	  from	  Höglund	  et	  al.	  (Höglund	  et	  al.,	  2006)	  who	  
also	  reported	  a	  scale-­‐free	  gene	  fusion	  network.	  
	  
Figure	   0-­‐5:	   Degree	   distribution	   for	   the	   2,941	   nodes	   in	   the	   gene	   fusion	   network	   (fusions	   and	   protein	   interactors).	   The	  




Figure	  0-­‐6:	  Degree	  distribution	  for	  the	  200	  gene	  fusion	  nodes	  in	  the	  network.	  The	  distribution	  follows	  a	  power-­‐law.	  
	  
The	  control	  network	  has	  2,593	  nodes	  and	  6,384	  edges	  –	  348	  nodes	  and	  8,428	  edges	  less	  
than	   the	   fusion	   network.	   This	   network	   is	   also	   scale-­‐free.	   Since	   degree	   distribution	   follows	   a	  
power	   law	   in	   these	   two	   networks,	   we	   log	   transformed	   the	   degrees	   to	   achieve	   normal	  
distribution.	  Figure	  0-­‐7	  shows	  a	  boxplot	   for	   the	   log	   transformed	  degree	  of	  nodes	   in	   the	  gene	  
fusion	   test	   set	   compared	   to	   the	   control	   set.	   The	   test	   set	   average	   log	   degree	   is	   1.635	   with	  
standard	   deviation	   0.520	   and	   the	   control	   set	   average	   log	   degree	   is	   1.242	   with	   standard	  
deviation	   0.440.	   The	   two	   averages	   are	   significantly	   different	   with	   a	   p-­‐value	   less	   than	   0.001	  




Figure	  0-­‐7:	  Box	  plot	  showing	  the	  degrees	  of	  nodes	  in	  the	  test	  gene	  fusion	  network	  and	  the	  control	  gene	  fusion	  network.	  
	   	  
	   RNA-­‐binding	   protein	   EWS,	   coded	   by	   the	   Ewing	   sarcoma	   breakpoint	   region	   1	   (EWSR1)	  
gene,	  has	  the	  most	  protein-­‐protein	  interactions	  out	  of	  the	  set	  of	  resultant	  proteins	  in	  our	  gene	  
fusion	  dataset.	  Gene	  fusions	  involving	  the	  gene	  EWSR1	  have	  the	  highest	  degrees.	  Table	  8	  lists	  
gene	  fusions	  with	  tenth	  percentile	  degrees	  in	  the	  network,	  which	  we	  define	  as	  hubs.	  
Table	  8:	  Gene	  fusions	  with	  tenth	  percentile	  degrees	  in	  the	  true	  gene	  fusion	  network.	  
	   Rank	   	   	   Gene	  Fusion	   Degree	   Rank	   Gene	  Fusion	   Degree	  
	   1	   	   	   YY1/EWSR1	   275	   9	   EWSR1/ATF1	   207	  
	   1	   	   	   EWSR1/YY1	   275	   10	   EWSR1/PBX1	   203	  
	   2	   	   	   EWSR1/CREB1	   272	   11	   EWSR1/WT1	   203	  
	   3	   	   	   PLAG1/CTNNB1	   258	   12	   EWSR1/FLI1	   203	  
	   3	   	   	   CTNNB1/PLAG1	   258	   13	   ACTB/GLI1	   197	  
	   4	   	   	   EWSR1/POU5F1	   235	   14	   EWSR1/ETV1	   197	  
	   5	   	   	   EWSR1/SMARCA5	   229	   15	   EWSR1/ERG	   196	  
	   6	   	   	   EWSR1/DDIT3	   218	   16	   EWSR1/NFATC1	   194	  
	   7	   	   	   EWSR1/SP3	   215	   17	   EWSR1/ZNF384	   193	  
	   8	   	   	   EWSR1/NFATC2	   209	   18	   EWSR1/NR4A3	   192	  
	   8	   	   	   NFATC2/EWSR1	   209	   19	   EWSR1/PATZ1	   191	  








From	  these	  analyses	  we	  gained	  three	  overarching	  conclusions:	  1)	  Motif	  discovery	  with	  
broad	   parameters	   at	   mixed-­‐cancer	   gene	   fusion	   breakpoints	   does	   not	   produce	   dependable	  
output,	  2)	  Gene	  fusion	  breakpoints	  likely	  occur	  at	  regions	  of	  relatively	  high	  entropy	  followed	  by	  
regions	  of	  relatively	  low	  entropy,	  and	  3)	  Network	  metrics	  may	  be	  useful	  toward	  understanding	  
the	  role	  gene	  fusions	  have	  in	  cancers.	  
This	  work	  is	  novel	  by	  the	  following	  points.	  Previously,	  no	  large-­‐scale	  motif	  discovery	  has	  
been	   performed	   at	   breakpoints	   that	   form	   gene	   fusions,	   nor	   have	   there	   been	   sliding-­‐window	  
entropy	  analyses	  to	  determine	  patterns	  in	  entropy	  at	  breakpoints.	  While	  gene	  fusion	  networks	  
have	   been	   built,	   our	   network	   is	   built	   from	   a	   large,	   composite,	   gene	   fusion	   dataset	   and	   our	  
networks	  metrics	  are	  unique	  to	  that	  dataset.	  
4.1. Gene	  fusion	  motif	  discovery	  
Motif	  discovery	  at	  regions	  surrounding	  gene-­‐fusion	  breakpoints	  yields	  eight	  statistically	  
significant	  motifs	  from	  the	  600	  and	  300	  base	  pair	  datasets.	  Nevertheless,	  closer	  examination	  of	  
the	  output	  shows	  evidence	   for	  overfitting,	  one	  of	   the	   limitations	   for	  motif	  discovery	   (Simcha,	  
Price,	   &	   Geman,	   2012).	   Each	   of	   the	   motifs	   contains	   the	   maximum	   number	   of	   base	   pairs	  
permitted	  at	  run-­‐time,	  which	  suggests	  generous	  substitutions	  were	  allowed	  to	  find	  a	  match.	  To	  
address	   overfitting,	  MacIsaac	   et	   al.	   (MacIsaac	  &	   Fraenkel,	   2006)	   suggested	   to	   perform	  motif	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discovery	  on	  a	  fraction	  of	  the	  dataset	  followed	  by	  the	  evaluation	  of	  the	  motifs	  using	  the	  held-­‐
out	  data.	  This	  will	  yield	  an	  unbiased	  estimate	  of	  how	  well	   the	  motifs	  generalize	   to	  new	  data.	  
MEME	  automatically	  performs	   this	   function,	   so	  as	   an	  alternative	   investigation	   for	  overfitting,	  
we	  tried	  motif	  discovery	  against	  a	  similar	  size,	  similar	  GC	  content	  dataset	  of	  random	  sequences	  
and	  looked	  for	  like	  significance	  values	  in	  any	  motifs	  found.	  Unfortunately,	  output	  from	  control	  
sequences	   looked	  very	  similar	  to	  output	  from	  test	  sequences.	  We	  again	  saw	  highly	  significant	  
20-­‐base-­‐pair	   long	   motifs	   evenly	   distributed	   evenly	   across	   sequences.	   More	   evidence	   for	  
overfitting	   comes	   from	   comparing	   the	   motifs	   and	   their	   e-­‐values	   from	   the	   600	   base	   pair	  
sequences	  and	  the	  300	  base	  pair	  sequences.	  None	  of	  the	  motifs	  across	  the	  two	  files	  matches	  
although	  the	  e-­‐values	  fall	  in	  the	  same	  range.	  If	  a	  motif	  from	  the	  300	  base	  pair	  sequence	  output	  
was	  truly	  highly	  significant,	  it	  would	  certainly	  appear	  as	  a	  significant	  motif	  in	  the	  600	  base	  pair	  
sequence	  output	  as	  well.	  Based	  on	   the	   results	   from	  random	  sequence	  motifs	  and	   the	   lack	  of	  
motif	  overlap	  across	  600	  and	  300	  base	  pair	  test	  sequences,	  we	  conclude	  that	  motifs	  from	  our	  
test	  set	  are	  not	  reliable.	  	  
It	   is	   likely	   that	   the	   size	   and	   range	   of	   the	   gene-­‐fusion	   breakpoint	   datasets	   are	   in	   part	  
responsible	   for	   poor	   performance	   from	   motif	   discovery.	   Nevertheless,	   there	   is	   currently	   no	  
information	   that	   helps	   predict	   targeted	   regions	  where	  motifs	   exist	   in	   relation	   to	   gene-­‐fusion	  
breakpoints.	   Segregating	   the	   dataset	   into	   smaller	   ranges	   may	   reduce	   overfitting,	   but	   new	  
complications	  arise.	  For	  example,	  if	  motifs	  exist	  in	  different	  ranges	  in	  different	  genes,	  they	  will	  
be	  partitioned	   from	  one	  another,	  and	  not	  appear	  as	   statistically	   significant	  motifs	   in	   the	  split	  
data	  set.	  Refining	  motif	  discovery	  for	  this	  dataset	  is	  an	  achievable	  task,	  but	  it	  requires	  planning	  
to	  preempt	  potential	  drawbacks.	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The	   three	   over-­‐represented	   transcription	   factor	   binding	   sites	   near	   breakpoints	   are	  
muscle	  initiator	  sequences-­‐19,	  TATA	  box,	  and	  muscle	  initiator.	  The	  TATA	  box	   is	  ubiquitous	  and	  
at	  a	   test	   to	  control	   ratio	  of	  1.45,	   it	   is	   statistically	  enriched.	  Muscle	   initiator	  sequences-­‐19	  and	  
muscle	  initiator	  are	  two	  similar	  muscle	  promoters	  –	  they	  are	  both	  21	  bps	  long	  and	  62%	  identical	  
(13	  matched	  nucleotides).	  This	  is	  an	  interesting	  finding	  that	  raises	  questions	  about	  gene	  fusion	  
formation	   across	   tissue	   types.	   Does	   gene	   fusion	   formation	   occur	   by	   similar	   mechanisms	  
regardless	  of	  tissue	  type	  or	  are	  there	  tissue-­‐specific	  expedients?	  Although	  we	  know	  these	  two	  
muscle-­‐promoter	   sequences	   are	   enriched	   near	   breakpoints	   in	   this	   dataset,	   it	   is	   necessary	   to	  
check	  for	  similar	  enrichment	   in	  a	  different	  dataset	  to	  make	  definitive	  conclusions.	  As	  COSMIC	  
gathers	  additional	  gene	   fusion	  data	  and	  their	  cancer	   type	  of	  origin,	  we	  can	  test	   for	   the	  same	  
enrichment	   pattern	   at	   new	   breakpoints,	   and	   thus	   gain	   support	   or	   dissuasion	   that	   these	  
transcription	  factor	  binding	  sites	  are	  of	  interest	  in	  gene	  fusion	  research.	  
4.2. Gene	  fusion	  entropy	  analysis	  
The	   sliding	   entropy	   analysis	   shows	   a	   pattern	   that	   breakpoints	   occur	   at	   relatively	   high	  
entropy	  regions	  followed	  by	  relatively	  low	  entropy	  regions.	  Nevertheless,	  the	  high	  entropy	  and	  
low	  entropy	  regions	  are	  not	  significantly	  higher	  or	  lower	  than	  entropy	  measurements	  in	  control	  
sequences.	  The	  difference	  between	  the	  test	  and	  control	  entropy	  reads	  is	  in	  the	  spatial	  distance	  
between	  the	  maximum	  and	  minimum	  entropy	  sequences.	  In	  the	  test	  set,	  the	  change	  from	  the	  
maximum	  to	  minimum	  entropy	  occurs	  over	  45	  base	  pairs,	  while	   in	  the	  control	  set	  the	  change	  
occurs	  over	  320	  base	  pairs.	  The	  sharpest	  change	  in	  the	  control	  set	  is	  15.15%	  over	  45	  base	  pairs,	  
compared	   to	  17.29%	  over	  45	  base	  pairs	   in	   the	   test	   set,	   and	   the	  percentages	  are	   significantly	  
different	  with	  a	  p-­‐value	  less	  than	  0.0001.	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Although	  error	  bars	  overlap,	  the	  difference	  between	  maximum	  and	  minimum	  entropy	  in	  
the	  test	  set	  is	  significant	  with	  a	  p-­‐value	  of	  0.0004.	  The	  breakpoints	  occurring	  at	  relatively	  high	  
entropy	   regions	   is	   in	   accordance	  with	  Gatlin’s	   statement	   that	   low	   redundancy	   (high	  entropy)	  
DNA	  molecules	  may	  have	  higher	   probability	   of	   error	   (Gatlin,	   1968).	  A	   relatively	   high	   entropy	  
region	   followed	   by	   a	   relatively	   low	   entropy	   region	   may	   be	   a	   structure	   that	   facilitates	   gene	  
fusion	  formation.	  	  
Entropy	   signatures	   are	   less	   specific	   than	   motifs,	   but	   these	   results	   support	   that	   gene	  
fusions	  do	  not	  occur	  randomly	  and	  are	  more	  likely	  to	  occur	  at	  region	  of	  relatively	  high	  entropy	  
shortly	  followed	  by	  a	  region	  of	  relatively	  low	  entropy.	  This	  observation	  could	  be	  applied	  to	  gene	  
fusion	   detection	   –	   gene	   fusion	   detection	   algorithms	   can	   include	   entropy-­‐change	   checks	   to	  
correct	  type	  II	  errors	  (false	  negatives).	  If	  a	  gene-­‐fusion-­‐detection	  algorithm	  based	  on	  sequence	  
alone	  overlooks	  a	  gene	  fusion,	  a	  second	  pass	  checking	  changes	  in	  entropy	  could	  bring	  attention	  
to	  the	  break	  for	  validation.	  However,	  before	  expanding	  gene-­‐fusion-­‐detection	  algorithms	  based	  
on	  these	  findings,	  it	  is	  first	  necessary	  to	  collect	  gene	  fusion	  data	  from	  intronic	  breakpoints,	  and	  
determine	  if	  the	  breaks	  happen	  at	  similar	  patterns.	  These	  results	  only	  define	  breaks	   in	  exonic	  
regions,	  which	  is	  an	  unknown	  fraction	  of	  the	  total	  number	  of	  breakpoints	  that	  form	  fusions.	  
4.3. Gene	  fusion	  network	  analysis	  
The	   network	   analysis	   affirms	   two	   observations	   on	   gene	   fusion	   networks:	   gene	   fusion	  
networks	   conform	   to	   power-­‐law	   degree	   distributions	   found	   in	   naturally	   occurring	   networks,	  
and	  average	  log	  degree	  is	  higher	  in	  true	  gene	  fusion	  networks	  compared	  to	  controls.	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The	   gene-­‐fusion	   network’s	   degree	   distribution	   follows	   a	   power-­‐law,	   therefore	   the	  
network	  is	  scale-­‐free	  rather	  than	  random	  (which	  would	  have	  a	  normal	  degree	  distribution)	  and	  
contains	  hub	  genes.	  The	  hub	  genes	  in	  the	  network	  support	  that	  selection	  for	  gene	  fusion	  occurs	  
during	   tumorigenesis.	   There	  are	   “promiscuous”	  genes	   that	   are	  more	   likely	   to	   form	   fusions	   in	  
cancer,	  and	  they	  do	  so	  with	  a	  range	  of	  partners.	  If	  gene	  fusion	  formation	  is	  a	  random	  process,	  
than	   there	  would	  be	  equal	  distribution	   for	   the	  genes	   involved	   in	   fusions.	  These	   results	  agree	  
with	  the	  entropy	  analysis,	  which	  supports	  that	  gene	  fusion	  breakpoints	  do	  not	  occur	  at	  random	  
sequences,	  but	  are	  more	  likely	  to	  occur	  at	  regions	  of	  relatively	  high	  entropy	  regions	  followed	  by	  
relatively	   low	  entropy	   regions.	   If	   these	   regions	   are	   enriched	   in	   a	   specific	   gene,	   the	   gene	  will	  
have	  a	  higher	  probability	  to	  form	  fusions.	  
Degree	  can	  be	  thought	  of	  as	  a	  measure	  for	  the	  impact	  a	  gene	  fusion	  has	  within	  the	  cell	  –	  
the	  more	  interactions	  a	  gene’s	  protein	  product	  has,	  the	  more	  disruptions	  will	  occur	  after	  fusion	  
events.	   We	   reject	   the	   hypothesis	   that	   average	   log	   degrees	   are	   the	   same	   in	   observed-­‐gene-­‐
fusion	   networks	   and	   networks	   built	   with	   randomly	   generated	   gene	   fusions	   with	   a	   p-­‐value	  
<0.001.	  We	  support	  the	  idea	  that	  gene	  fusions	  are	  more	  likely	  to	  be	  cancer-­‐causal	  if	  the	  genes	  
participating	  in	  the	  fusion	  interact	  with	  many	  proteins	  (higher	  than	  average	  degree).	  
Fourteen	  out	  of	  sixteen	  fusions	  with	  top	  ten	  highest	  degrees	  contain	  the	  gene	  EWSR1.	  
EWSR1	  encodes	  a	  protein	  involved	  in	  meiotic	  cell	  division,	  DNA	  repair	  mechanisms,	  and	  cellular	  
ageing	  (Li	  et	  al.,	  2007).	  It	  is	  a	  promiscuous	  gene	  that	  form	  fusions	  with	  several	  partner	  genes	  in	  
a	  variety	  of	  soft	  tissue	  tumors	  (reviewed	  in	  (Fisher,	  2014)).	  The	  large	  number	  of	  EWSR1	  fusions	  
found	  in	  cancer	  tissue	  suggests	  driver	  ability	  and	  selection.	  The	  fusions	  with	  degrees	  falling	  in	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the	  top	  ten	  that	  do	  not	  involve	  EWSR1	  are	  those	  with	  pleiomorphic	  adenoma	  gene	  1	  (PLAG1)	  
and	  catenin	  beta	  1	  (CTNNB1).	  PLAG1	  encodes	  a	  zinc	  finger	  protein,	  and	  activation	  is	  a	  recurrent	  
observation	   in	   lipoblastomas	   (Astrom	   et	   al.,	   n.d.).	   CTNNB1	   mutations	   are	   found	   in	   prostate	  
cancer	  (Gerstein	  et	  al.,	  2002)	  and	  ovarian	  carcinomas	  (Palacios	  &	  Gamallo,	  1998).	  High-­‐degree	  
gene	  fusions	  involve	  genes	  reported	  in	  literature	  with	  roles	  in	  cancer.	  The	  roles	  of	  the	  individual	  
genes	  prior	  to	  fusion	  events	  are	  indicators	  of	  their	  role	  after	  gene	  fusion	  events.	  Therefore,	  the	  
union	  of	  interactions	  for	  the	  resultant	  proteins	  in	  the	  gene	  fusion	  network	  acts	  as	  an	  indicator	  
for	  the	  fusion’s	  impact.	  
The	  gene	  fusion	  network	  is	  a	  useful	  tool	  for	  visualizing	  and	  measuring	  the	  impact	  a	  gene	  
fusion	   has	   within	   the	   cell.	   The	   network	   shows	   that	   some	   genes	   (hubs)	   are	  more	   likely	   than	  
others	   to	   form	   fusions,	   therefore	   could	   be	   positively	   selected	   for	   during	   tumorigenesis,	   and	  
have	  more	  driver	  potential	  compared	  to	  fusions	  with	  less-­‐common	  genes.	  
4.4. Project	  Limitations	  
The	  currently	  available	  algorithms	  for	  motif	  discovery	  have	  individual	   limitations.	   In	  an	  
assessment	   on	   the	   DNA	   motif	   discovery	   algorithms,	   Simcha	   et	   al.	   reported	   that	   algorithms	  
dependent	  on	  background	  models	  (like	  MEME)	  are	  ‘‘too	  null’’	  which	  means	  they	  result	  in	  overly	  
optimistic	   significance	   assessments	   (Simcha	   et	   al.,	   2012).	   This	   explains	   the	   overfitting	   that	  
occurred	  in	  our	  analysis,	  and	  suggests	  that	  to	  reduce	  limitations,	  try	  alternative	  motif	  discovery	  
tools	  and	  compare	  results.	  	  
The	   motif	   discovery	   and	   entropy	   analysis	   are	   limited	   by	   the	   reliability	   of	   the	   data	  
sources.	  We	  depend	  on	  sequencing	  data	  and	  exact	  breakpoint	  positions	   in	  these	  studies,	  and	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recognize	   that	   error	   in	   the	   reported	   nucleotide	   types	   and	   numbers	   can	   dampen	   results.	  
COSMIC	  collects	  gene	  fusion	  records	  from	  various	  sources,	  and	  if	  the	  breakpoint	  positions	  are	  
reported	  in	  different	  ways	  depending	  on	  the	  source	  (for	  example,	  the	  first	  nucleotide	  is	  number	  
0	  from	  some	  sources	  and	  1	  from	  others),	   the	  entropy	  analysis	   loses	  some	  of	   its	  power.	  Motif	  
results	   are	   less	   affected	   by	   small	   shifts	   because	   the	   sequences	   are	   aligned	   around	   the	  
breakpoints.	  Nevertheless,	   incorrect	  sequencing	  data	   inhibits	  motif	  discovery	  algorithms	  from	  
finding	   best	   fits,	   and	   may	   even	   lead	   to	   false	   positives	   if	   multiple	   incorrect	   sequences	   are	  
incorporated.	  We	  very	  much	  depend	  on	  the	  data	  quality	  and	  integrity	  of	  others	  in	  the	  scientific	  
community	  for	  these	  analyses.	  
Motif	  discovery,	  entropy	  analysis,	  and	  network	  analysis	  are	  all	  limited	  by	  our	  data	  set’s	  
size.	   COSMIC	  holds	   records	   for	   over	   nine	   thousand	   gene	   fusions,	   but	   less	   than	  10%	  of	   those	  
records	  have	   sequence	   information,	   and	  only	   a	   third	  of	   those	   are	  unique	   records.	   There	   is	   a	  
plethora	  of	  unrecorded	  gene	  fusion	  information	  that,	  once	  collected,	  will	  give	  studies	  like	  these	  
and	  many	  others	  a	  significant	  amount	  of	  power.	  As	  more	  information	  on	  gene	  fusions	  becomes	  
publicly	   available,	   all	   of	   these	   studies	   can	   be	   repeated	   to	   yield	   results	   that	   are	   more	  
dependable.	  
4.5. Future	  Work	  
We	   plan	   to	   improve	   upon	   the	   motif	   discovery	   analysis	   by	   repeating	   our	   steps	   with	  
alternative	   motif	   discovery	   tools.	   In	   this	   study	   we	   utilized	   MEME	   suite,	   which	   uses	   a	  
deterministic	   optimization	   algorithm.	   We	   found	   two	   alternative	   motif	   discovery	   tools	   with	  
competitive	   performance:	   W-­‐AlignACE,	   which	   uses	   Gibb	   sampling	   and	   a	   probabilistic	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optimization	   algorithm	   (Chen,	   Guo,	   Fan,	   &	   Jiang,	   2008),	   and	  Weeder,	   an	   enumerative	  motif	  
discovery	   program	   (Pavesi,	  Mereghetti,	  Mauri,	  &	   Pesole,	   2004).	  We	   hope	   that	   by	   comparing	  
results	   from	   these	   three	   tools,	   we	   will	   gain	   power	   and	   be	   able	   to	   definitively	   conclude	  
overfitting	   or	   lessen	   it.	  We	   plan	   to	   perform	  motif	   discovery	   at	   the	   amino	   acid	   level	   around	  
exonic	   breakpoints.	   Degeneracy	   in	   the	   genetic	   code	   may	   lead	   to	   false	   negatives	   in	   motif	  
discovery.	   Checking	   for	   motifs	   at	   the	   amino	   acid	   level	   may	   help	   reduce	   differences	   in	   the	  
sequences	  caused	  by	  degeneracy.	  
We	   plan	   to	   expand	   out	   entropy	   analysis	   by	   validating	   our	   exonic-­‐breakpoint-­‐entropy-­‐
pattern	   against	   intronic-­‐breakpoint-­‐entropy-­‐patterns.	   We	   must	   find	   data	   sources	   for	   gene	  
fusions	   sequences	   from	  genomic	  DNA	   rather	   than	  mRNA	   to	  account	   for	   intronic	  breakpoints.	  
Data	   is	   the	   limiting	   factor	   for	   this	   study,	   but	   we	   will	   collect	   sequence	   data	   as	   it	   becomes	  
available.	   The	   rapidly	   evolving	  NGS	   technologies	   have	  helped	   investigators	   to	   generate	  more	  
and	   more	   whole	   genome	   sequencing	   data,	   which	   will	   provide	   gene	   fusion	   breakpoints	   in	  
intronic	   regions.	   If	   we	   are	   able	   to	   confirm	   our	   entropy	   pattern	   in	   both	   exonic	   and	   intronic	  
breakpoints	   that	   form	   fusions,	  we	   can	  expand	  on	  a	  gene-­‐fusion-­‐detection	  algorithm	  by	  using	  
entropy	  checks	  as	  a	  means	  to	  reduce	  false	  negatives	  in	  gene-­‐fusion	  detection.	  
To	   further	   our	   network	   analysis,	   we	   plan	   to	   map	   Gene	   Ontology	   terms	   to	   genes	  
participating	  in	  fusions	  and	  examine	  their	  functional	  enrichment.	  We	  believe	  this	  will	  highlight	  
gene	  fusion	  groups	  common	  in	  cancer,	  like	  the	  tyrosine	  kinase	  fusions.	  Preliminary	  work	  for	  this	  
step	  yielded	  hundreds	  of	  overrepresented	  Gene	  Ontology	  terms.	  Our	  current	  focus	  is	  reducing	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noise	  by	  parsing	  the	  network	  into	  like-­‐components	  (i.e.	  extracting	  subnetworks	  based	  on	  tissue	  
of	  origin).	  
To	   advance	   this	   project,	   we	   plan	   to	   take	   advantage	   of	   the	   available	   gene-­‐fusion	  
sequence	   data	   and	   perform	   a	   survey	   on	   protein	   domain	   shuffling.	   We	   will	   explore	   the	  
possibility	   of	   differentiating	   gene	   fusion	   drivers	   through	   shuffled	   substrate	   binding	   sites.	  We	  
appreciate	   that	   the	  growing	  pool	  of	  gene	   fusion	   information	   incites	  creative	   investigations	   to	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Code	  for	  sliding-­‐window	  entropy	  calculations	  
#!/usr/bin/perl 
# 
#This program designates a window of width $FL (frame length) in which to 
calculate entropy 
#and move the window along input sequences shifting width $SL (shift length) 
along the desired 
#region 2*DL (desired length) centered at a breakpoint 
# 
#Author: Morgan Harrell 
 
#FRAME LENGTH 
$FL = 20; 
#SHIFT LENGTH 
$SL = 5; 
#HALF LENGTH DESIRED AROUND BREAKPOINT 
$DL = 300; 
 
#Open exon breakpoint ID list 
#Form: 
#mRNA,breakpoint position,gene name_chromosome 
#NM_004083.4,837,DDIT3_12 
open (EID, "exonBP.info.NoRepeats") || die ("Cannot find input list\n"); 
while (<EID>) 
{ 
    chomp($_); 
    my @values = split(',', $_); 
    #Get DNA sequence for the gene with an exonic breakpoint 
    open (mRNA, "/gpfs22/home/harrelm/data/COSMIC/geneSeq/genes/$values[2]") 
|| print "Cannot find 
/gpfs22/home/harrelm/data/COSMIC/geneSeq/genes/$values[2]\n"; 
    my @sequence = <DNA>; 
    close(DNA); 
     
    #Prep output 
    print "$values[2]\t"; 
     
    #Set up slider loop 
    my $length = length($sequence[1]); 
    my $start = $values[1] - $DL; 
    #Prevents negative number in the event that the breakpoint is not more 
than DL nucleotides 
    #into the sequence 
    if ($start < 0) 
    { 
        $start = 0; 
    } 
    my $end = $values[1] + $DL; 
54	  
	  
    #Prevents overarching number in the event that the breakpoint is not more 
than DL nucleotides 
    #from the end of the sequence 
    if ($start > $length) 
    { 
        $start = $length; 
    } 
     
    #Slide and calculate entropy 
    for (my $i = $start; $i+$FL < $end; $i+=$SL) 
    { 
        my $seqSub = substr($sequence[1], $i, $FL); 
        #Sequence entropy 
        my $sse = &entropy($seqSub); 
        #Print entropy 
        print "$sse\t"; 
    } 






    my $string = @_[0]; 
    my %Count; 
    my $total = 0; 
    foreach my $char (split(//, $string))  
    { 
       $Count{$char}++;                
       $total++;                       
    } 
    my $H = 0;                         
    foreach my $char (keys %Count)  
    {   
        my $p = $Count{$char}/$total;  
        $H += $p * log($p);            
    } 
    $H = -$H/log(2);                     
} 
	  
